[1] Feldman BM, Rider LG, Reed AM, et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet, 2008, 371(9631): 2201-2212 [2]Gitiaux C, Kostallari E, Lafuste P, et al. Whole microvascular unit deletions in dermatomyositis. Ann Rheum Dis, 2013, 72(3): 445-452 [3] Schneider KO, Braeuninger C, Bergmann F, et al. The Importance of Computed Tomography for the Diagnosis Of Duodenal Perforation in a Paediatric Patient with Juvenile Dermatomyositis. Klin Padiatr, 2016, 228(4): 216-218 [4] See Y, Martin K, Rooney M, et al. Severe juvenile dermatomyositis complicated by pancreatitis. Br J Rheumatol, 1997, 36(8): 912-916 [5] Downey EC Jr, Woolley MM, Hanson V. Required surgical therapy in the pediatric patient with dermatomyositis. Arch Surg, 1988, 123(9): 1117-1120 [6]Wang IJ, Hsu WM, Shun CT, et al. Juvenile dermatomyositis complicated with vasculitis and duodenal perforation. J Formos Med Assoc, 2001, 100(12): 844-846 [7] Singh S, Suri D, Aulakh R, et al. Mortality in children with juvenile ermatomyositis: two decades of experience from a single tertiary care centre in North India. Clin Rheumatol, 2014, 33 (11) : 1675-1679 [8] Schullinger JN, Jacobs JC, Berdon WE. Diagnosis and management of gastrointestinal perforations in childhood dermatomyositis with particular reference to perforations of the duodenum. J Pediatr Surg, 1985, 20(5): 521-524 [9] Miller LC, Michael AF, Kim Y. Childhood Dermatomyositis. Clin Pediatr (Phila), 1987, 26 (11): 561-566 [10] Morita Y, Sakuta T, Nagasu H, et al. Bilateral ureteral stenosis and duodenal perforation in a patient with dermatomyositis. Mod Rheumatol, 2007, 17(1): 54-56 [11] Ichimura Y, Matsushita T, Hamaguchi Y. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis, 2012, 71(5): 710-713 [12]Rogers A, Chung L, Li S, et al. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients. Arthritis Care Res (Hoboken), 2017, 69(12): 1909-1914 [13]Tansley SL, Betteridge ZE, Shaddick G, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford), 2014, 53(12): 2204-2208 [14]Aouizerate J, De Antonio M, Bader-Meunier B, et al. Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis. Rheumatology (Oxford), 2018, 57(5): 873-879 |